On May 28, the 20th China International Laboratory Medicine and Blood Transfusion Instrument Reagents Expo (referred to as "CACLP"), the 3rd China International IVD Upstream Raw Material Manufacturing and Circulation Supply Chain Expo (referred to as "CISCE") opened in Nanchang Greenland International Expo Center.


With the theme of "getting on a new journey with the power of the brand", more than 1,300 enterprises from the whole industry chain of in vitro diagnosis, middle and downstream from more than 20 countries and regions at home and abroad signed up for the exhibition, and the number of visitors is expected to exceed 40,000.


 

In vitro diagnosis, that is, IVD, refers to the products and services that obtain clinical diagnostic information through the detection of human samples (blood, body fluids, tissues, etc.) outside the human body to diagnose diseases or body functions.

 

According to the data of Observation and Research Report Network, the size of China's in vitro diagnostic market increased from about 42.75 billion yuan in 2015 to about 80.57 billion yuan in 2019, with an annual compound growth rate of 17.2%. It is expected that by 2023, the size of China's in vitro diagnostic market will grow to 148.49 billion yuan.


 

The scale of the in vitro diagnostic industry continues to expand, among which the development of portable in vitro diagnostic equipment and in vitro management platform should not be underestimated.

 

"Everything is accelerating" in modern society seems to have become a basic life experience. Life seems to be pushed away, and the gap between rest becomes few. Under such circumstances, people choose faster transportation, faster Internet, and watch videos twice as fast as before. They don't even have the patience to read this article. Most people do not want to spend 2-3 hours in the hospital for basic health testing. Based on this, portable medical testing equipment and CKD digital health management platform will be a trend of health testing and management in the future.

 

Palm Urine Analyzer

 

Empsun Medical is the first portable handheld urine analyzer in the world, obtained a registration certificate in 2011 and passed CMD ISO13485 certification. The products sell well in various provinces and regions in China and are sold all over the world. Home test, easy to operate, with 14 urine test indicators, you can understand your physical health in 1 minute.


 

 

CKD Digital Health Management Platform

 

Empsun has developed an advanced CKD out-of-hospital management platform. It provides customers with family doctor consultation services, multi-dimensional urine routine data collection and detection and analysis, timely health reminders and knowledge popularization push, etc. We aim to offer customers the professional medical services of the hospital at any time.

 

Empsun has been adhering to the corporate mission of " benefiting all sentient beings and the world" and has been devoting itself to the research and development, promotion and application of POCT products in the field of IVD. In addition to the traditional R&D, production, sales and after-sales service, Empsun innovates and expands the field of digital medicine, does the deep integration of the Internet and medical care, does public home health management, and provides one-stop convenient health management services integrating "equipment + detection + diagnosis and treatment". As a "leading platform for the health industry based on POCT", Empsun will comprehensively build professional, high-precision and convenient household equipment and instruments to meet the diversified and multi-level medical needs of the public.